The interim data showed that cancer DNA levels dropped by 97.7% in the Cema-Cel group, while rising by 26.6% in the observation group. ・Allogene said the trial is ongoing across more than 60 sites and ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) secured a spot on our list of the best penny stocks set to explode. As of April 8, ...

Google’s scattershot messaging strategy has one less problem. Starting today, Android users can log in to Allo on the web to see and send messages, but it probably won’t make the chat platform more ...

Allogene (ALLO) stock jumped 41% on promising ALPHA3 trial data showing 58% MRD clearance with no CAR T toxicities. Baird ups target to $9.

Four months after announcing the product at Google I/O, Google Allo has finally launched. Allo is yet another attempt at a Google instant messaging platform, and while Google insists it won’t shut ...

The next time you need to Google something, you may end up doing so via text message rather than typing in a search query or saying “Ok, Google.” That’s part of the idea behind Allo, the search ...

Allogene Therapeutics (NASDAQ:ALLO) said new pre-clinical data for its investigational CAR-T therapy ALLO-329 have been ...

Add Yahoo as a preferred source to see more of our stories on Google. In a turn of events pretty much everyone outside of Google saw coming, the search giant is apparently poised to wind down its ...

Google’s AI-powered Allo messaging app isn’t just on smartphones anymore. On Tuesday, the search giant launched Allo for web, a companion web app that puts the messaging service’s core features in ...

Google took the veil off a new messaging app today and it's called Allo. It's not a Hangouts replacement but rather a standalone app that looks kind of like Facebook Messenger or Whatsapp. The key ...